Trial intelligence / Profile preview

Sildenafil in Fontan Patients: Pulmonary Circulation and Ventricular Hemodynamics

2012-001784-77Phase 2Completed

Sponsor
UZ Leuven
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of sildenafil in Cardiovascular Malformation (CVM) and pulmonary vascular disease (PVD), sponsored by UZ Leuven. Primary endpoint: Stroke volume during exercise. Started Apr 2012; status: completed.

02

Drugs

sildenafil
03

Conditions

Cardiovascular Malformation (CVM)pulmonary vascular disease (PVD)

Beyond the preview

Go deeper on 2012-001784-77.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001784-77.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call